Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particles
Sherry, L.; Bahar, M. W.; Porta, C.; Fox, H.; Grehan, K.; Nasta, V.; Duyvesteyn, H. M.; de Colibus, L.; Marsian, J.; Murdoch, I.; Ponndorf, D.; Kim, S.-R.; Shah, S.; Carlyle, S.; Swanson, J. J.; Matthews, S.; Nicol, C.; Lomonossoff, G. P.; Macadam, A. J.; Fry, E. E.; Stuart, D. I.; Stonehouse, N. J.; Rowlands, D. J.
Show abstract
Polioviruses have caused crippling disease in humans for centuries, prior to the successful development of vaccines in the mid-1900s, which dramatically reduced disease prevalence. Continued use of these vaccines, however, threatens ultimate disease eradication and achievement of a polio-free world. Virus-like particles (VLPs) that lack a viral genome represent a safer potential vaccine, although they require particle stabilization. Using our previously established genetic techniques to stabilize the structural capsid proteins, we demonstrate production of poliovirus VLPs of all three serotypes, from four different recombinant expression systems. We compare the antigenicity, thermostability and immunogenicity of these stabilized VLPs against the current inactivated polio vaccine, demonstrating equivalent or superior immunogenicity. Structural analyses of these recombinant VLPs provide a rational understanding of the stabilizing mutations and the role of potential excipients. Collectively, we have established these poliovirus stabilized VLPs as viable next-generation vaccine candidates for the future.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques 95%
- Enhanced protective efficacy of a novel, thermostable, RBD-S2 fusion immunogen against SARS-CoV-2 and its variants 94%
- Targeting HIV Env immunogens to B cell follicles in non-human primates through immune complex or protein nanoparticle formulations 94%
Similar papers in this journal
Similar papers in this journal
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates 95%
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 94%
- The universal suppressor mutation in the HSV-1 nuclear egress complex restores membrane budding defects by stabilizing the oligomeric lattice 94%
Similar papers in this journal
- Dipeptidase 1 is a functional receptor for coronavirus PHEV 95%
- The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism 95%
- Infection cycle and phylogeny of the Polinton-like virus Phaeocystis globosa virus virophage-14T 93%
Similar papers in this journal
- A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease 96%
- Design of SARS-CoV-2 RBD Immunogens to Focus Immune Responses Towards Conserved Coronavirus Epitopes 95%
- Deep time structural evolution of retroviral and filoviral surface envelope proteins 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.